Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

[This corrects the article DOI: 10.1186/s13601-016-0116-9.]

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement.

Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of major interest in other medical domains like allergy and chronic airway diseases, which face an urgent need to improve the level of disease control, enhance patient satisfaction and increase effectiveness of preventive interventions. The combination of personalized care, prediction of treatment success, prevention of disease and patient participation in the elaboration of the treatment plan is expected to substantially improve the therapeutic approach for individuals suffering from chronic disabling conditions. Given the emerging data on the impact of patient stratification on treatment outcomes, European and American regulatory bodies support the principles of PM and its potential advantage over current treatment strategies. The aim of the current document was to propose a consensus on the position and gradual implementation of the principles of PM within existing adult treatment algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS). At the time of diagnosis, prediction of success of the initiated treatment and patient participation in the decision of the treatment plan can be implemented. The second-level approach ideally involves strategies to prevent progression of disease, in addition to prediction of success of therapy, and patient participation in the long-term therapeutic strategy. Endotype-driven treatment is part of a personalized approach and should be positioned at the tertiary level of care, given the efforts needed for its implementation and the high cost of molecular diagnosis and biological treatment

Physicalsystemmodellinglanguages : From Allan To Modelica

engineering design studies. For Gaz de France, these studies must satisfy exacting criteria of quality and rapidity. Studies are even more effective if models developed on previous occasions can be stored and reused and if the company is able to share models with its partners. The development of model exchanges is therefore a key factor determining the future scope of modelling/simulation activities

Barium and its Importance as an Indicator of (Paleo)Productivity

Barium (Ba) is a trace element which occurs predominantly as barite mineral (BaSO4) in the marine environment. Previous work suggests that barite concentrations are related to the organic carbon flux and marine biological debris in the water column suggesting a direct or indirect involvement in the marine biological cycling. In addition, barite has a high preservation rate (~30%) in sediments and it is less affected by early diagenesis than other proxies for productivity such as carbonates (~10%) and organic carbon (~1%), for example. Therefore, Ba is considered an excellent proxy for ocean (paleo)productivity. However, correlating barite to productivity involves some caveats. Specifically, the post-depositional formation of barite in oxic sediments can lead to Ba release into porewaters under anoxic conditions, which can form barite again under oxic conditions. This diagenetic formation is not correlated to export production as the seawater authigenic barite formed with decaying organic matter in the water column. Therefore, the main goal of this work is to briefly review the marine Ba cycle and highlight its importance for (paleo)productivity research